Terms: = Bone cancer AND GPC3, OCI-5, 2719, ENSG00000147257, SGBS, SGB, DGSX, SDYS, P51654, AC002420_1, SGBS1
14 results:
1. gpc3 and PEG10 peptides associated with placental gp96 elicit specific T cell immunity against hepatocellular carcinoma.
Qin L; Wang J; Cheng F; Cheng J; Zhang H; Zheng H; Liu Y; Liang Z; Wang B; Li C; Wang H; Ju Y; Tian H; Meng S
Cancer Immunol Immunother; 2023 Dec; 72(12):4337-4354. PubMed ID: 37932427
[TBL] [Abstract] [Full Text] [Related]
2. Frequently expressed glypican-3 as a promising novel therapeutic target for osteosarcomas.
Nie JH; Yang T; Li H; Li S; Li TT; Ye HS; Lu MD; Chu X; Zhong GQ; Zhou JL; Wu ML; Zhang Y; Liu J
Cancer Sci; 2022 Oct; 113(10):3618-3632. PubMed ID: 35946078
[TBL] [Abstract] [Full Text] [Related]
3. Impact of FLT3 Mutation on Outcomes after Venetoclax and Azacitidine for Patients with Treatment-Naïve Acute Myeloid Leukemia.
Konopleva M; Thirman MJ; Pratz KW; Garcia JS; Recher C; Pullarkat V; Kantarjian HM; DiNardo CD; Dail M; Duan Y; Chyla B; Potluri J; Miller CL; Wei AH
Clin Cancer Res; 2022 Jul; 28(13):2744-2752. PubMed ID: 35063965
[TBL] [Abstract] [Full Text] [Related]
4. Primary mediastinal germ cell tumours: an immunohistochemical and molecular diagnostic approach.
Fichtner A; Richter A; Filmar S; Kircher S; Rosenwald A; Küffer S; Nettersheim D; Oing C; Marx A; Ströbel P; Bremmer F
Histopathology; 2022 Jan; 80(2):381-396. PubMed ID: 34506648
[TBL] [Abstract] [Full Text] [Related]
5. Targeting acute myeloid leukemia cells by CD33 receptor-specific MoS
Štefík P; Annušová A; Lakatoš B; Elefantová K; Čepcová L; Hofbauerová M; Kálosi A; Jergel M; Majková E; Šiffalovič P
Biomed Mater; 2021 Aug; 16(5):. PubMed ID: 34280914
[TBL] [Abstract] [Full Text] [Related]
6. A prospective trial of vaccine to prevent hepatitis B virus reactivation after hematopoietic stem cell transplantation.
Nishikawa K; Kimura K; Kanda Y; Sugiyama M; Kakihana K; Doki N; Ohashi K; Bae SK; Takahashi K; Ishihara Y; Mizuno I; Onishi Y; Onozawa M; Onizuka M; Yamamoto M; Ishikawa T; Inoue K; Kusumoto S; Hashino S; Saito H; Kanto T; Sakamaki H; Mizokami M
Bone Marrow Transplant; 2020 Jul; 55(7):1388-1398. PubMed ID: 32071416
[TBL] [Abstract] [Full Text] [Related]
7. Association of Rare Coding Mutations With Alzheimer Disease and Other Dementias Among Adults of European Ancestry.
Patel D; Mez J; Vardarajan BN; Staley L; Chung J; Zhang X; Farrell JJ; Rynkiewicz MJ; Cannon-Albright LA; Teerlink CC; Stevens J; Corcoran C; Gonzalez Murcia JD; Lopez OL; Mayeux R; Haines JL; Pericak-Vance MA; Schellenberg G; Kauwe JSK; Lunetta KL; Farrer LA;
JAMA Netw Open; 2019 Mar; 2(3):e191350. PubMed ID: 30924900
[TBL] [Abstract] [Full Text] [Related]
8. Clinicopathological features and differential diagnosis of hepatocellular carcinoma in extrahepatic metastases.
Chen D; Li Z; Song Q; Qian L; Xie B; Zhu J
Medicine (Baltimore); 2018 Dec; 97(50):e13356. PubMed ID: 30557986
[TBL] [Abstract] [Full Text] [Related]
9. bone morphogenetic protein-9 is a potent growth inhibitor of hepatocellular carcinoma and reduces the liver cancer stem cells population.
Jung JW; Yoon SM; Kim S; Jeon YH; Yoon BH; Yang SG; Kim MK; Choe S; Kuo MM
Oncotarget; 2016 Nov; 7(45):73754-73768. PubMed ID: 27650540
[TBL] [Abstract] [Full Text] [Related]
10. Processing by convertases is not required for glypican-3-induced stimulation of hepatocellular carcinoma growth.
Capurro MI; Shi W; Sandal S; Filmus J
J Biol Chem; 2005 Dec; 280(50):41201-6. PubMed ID: 16227623
[TBL] [Abstract] [Full Text] [Related]
11. Mouse homologue of a novel human oncofetal antigen, glypican-3, evokes T-cell-mediated tumor rejection without autoimmune reactions in mice.
Nakatsura T; Komori H; Kubo T; Yoshitake Y; Senju S; Katagiri T; Furukawa Y; Ogawa M; Nakamura Y; Nishimura Y
Clin Cancer Res; 2004 Dec; 10(24):8630-40. PubMed ID: 15623647
[TBL] [Abstract] [Full Text] [Related]
12. Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling.
Midorikawa Y; Ishikawa S; Iwanari H; Imamura T; Sakamoto H; Miyazono K; Kodama T; Makuuchi M; Aburatani H
Int J Cancer; 2003 Feb; 103(4):455-65. PubMed ID: 12478660
[TBL] [Abstract] [Full Text] [Related]
13. [Comparative biomechanical compression trials with a new vertebral prosthetic implant].
Knop C; Lange U; Bastian L; Oeser M; Blauth M
Unfallchirurg; 2001 Jan; 104(1):25-33. PubMed ID: 11381759
[TBL] [Abstract] [Full Text] [Related]
14. Simpson Golabi Behmel syndrome: progress toward understanding the molecular basis for overgrowth, malformation, and cancer predisposition.
DeBaun MR; Ess J; Saunders S
Mol Genet Metab; 2001 Apr; 72(4):279-86. PubMed ID: 11286501
[TBL] [Abstract] [Full Text] [Related]
